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doi:10.1Objectives: Right ventricular (RV) function is compromised in 25% of left ventricular (LV) assist device
recipients despite effective LV support. The risk of such dysfunction has been enhanced by an ischemic or
undamaged interventricular septum; however, we found septal infarction to be paradoxically protective. We,
therefore, evaluated the potential of nonsurround, nonuniform, biventricular-capable direct cardiac compression
(DCC) (using the HeartPatch DCC) to overcome RV dysfunction in hearts with a normal or infarcted interven-
tricular septum.
Methods: Ethanol ablation was used to create an interventricular septal infarction in 6 sheep, and 6 others served
as the control sheep. The load-independent and in-series RV response to DCC was assessed using sonomicrom-
eter heart dimension sensors. Triphenyltetrazolium perfusion delineated the septal damage.
Results: LVDCC caused a greater increase of the RV preload recruitable strokework in the control sheep than in
the study sheep (190.6  23.5 and 135.0  40.8 erg*10^3, respectively, P<.001). In contrast, RVend-systolic
elastance increased more in the septal-ablated sheep with RV DCC (17.29 3.40 vs 9.88 2.01 mm Hg/mL in
the control sheep, P<.001). Abnormal RV diastolic function before device insertion in the septal-ablated sheep
was normalized with both passive DCC placement and after activation (RV diastolic relaxation constant 23.5
2.3 and 20.0  2.1 ms, respectively, P<.001). Both biventricular and RV DCC actuation increased the RV sys-
tolic pressure more in the septal-ablated sheep than in the control sheep (37.9  6.3 and 47.7  4.6 mm Hg vs
29.7% 4.8% and 40.3% 8.3%, respectively, P<.001). In contrast, the RVend-systolic diameter decreased
more during LV DCC (70.1%  15.9% vs 90.5%  5.0%, P<.001).
Conclusions: The HeartPatch DCC support of LV and RV function results from improvement of the systolic
septal-lateral fractional change that is not influenced by septal infarction. The latter attenuated LV to RV device
energy delivery during LV patch actuation but enhanced RV energy delivery during RV patch actuation. This
DCC technique can provide effective support in high-risk RV failure situations arising from left ventricular assist
device use. (J Thorac Cardiovasc Surg 2011;142:209-15)Implantation of left ventricular (LV) assist devices (LVADs)
for the treatment of heart failure has increased in the post-
Randomized Evaluation of Mechanical Assistance in
the Treatment of Congestive Heart failure (REMATCH)
era,1-4 with several devices approved as destination
therapy.2,5 However, major issues remain because of the
risk of thromboembolism, bleeding, and pump failure, as
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Spostoperative right ventricular (RV) failure, which has
affected up to 25% of device recipients.6-10 Recent
reports have suggested the latter is of greater significance
than previously thought, often requiring additional
support for the right-sided circulation.11 An alternative
technology-based approach to these shortcomings relies
on epicardial systolic augmentation by direct cardiac com-
pression (DCC), which avoids many of the drawbacks of the
in-line blood-contacting biventricular assist devices.12
DCC has been implemented in various forms during the
past 50 years, including a pneumatic-driven rigid heart-
encircling ‘‘cup’’13 and a ‘‘copulsation’’ device14 that as-
sists the left and/or right ventricles. Despite improving the
LVand RV cardiac output andmyocardial energy efficiency,
these devices have displayed static enhancement of ventric-
ular function, without improvements to load-independent
indexes and, thus, have relied on high-filling volumes to
maintain a suitable mechanical therapeutic window.
Furthermore, the heart-surrounding configuration of such
devices is likely to constrain ventricular filling and impairrdiovascular Surgery c Volume 142, Number 1 209
FIGURE 1. Diagrammatic representation of HeartPatch direct cardiac
compression device. Each patch was designed to conform to either the
left ventricular or right ventricular contour and consisted of a thin inner
and thicker outer wall. The shape and mechanical properties of the walls
were designed using finite element modeling to achieve maximal inward
volume displacement during inflation.
Abbreviations and Acronyms
DCC ¼ direct cardiac compression
ED ¼ end-diastolic
Ees ¼ end-systolic elastance
ES ¼ end-systolic
ESPVR ¼ ES pressure/volume relationship
LV ¼ left ventricular
LVAD ¼ left ventricular assist device
MSPA ¼ main septal perforating artery
PRSW ¼ preload recruitable stroke work
PTSMA ¼ percutaneous transluminal septal
myocardial ablation of the artery
RV ¼ right ventricular
SW ¼ stroke work
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Searly diastolic relaxation. To overcome such shortcomings,
we used a novel design consisting of independent nonsur-
round RV- and LV-apposed pumping chambers
(HeartPatch-DCC device; Heart Assist Technologies, St
Leonards, NSW, Australia; Figure 1), which has been
shown to have potent ability to increase cardiac output15
and restore myocardial efficiency during pharmacologically
induced heart failure.16 This device was implanted in sheep
hearts with septal pathologic features, as previously de-
scribed,17 to compare the RV in-series, load-independent,
and geometric responses to that of previously studied inline
mechanical LVAD unloading.MATERIALS AND METHODS
A total of 15 Border-Leicester cross sheep (body weight, 59.0 7.1 kg)
were used in the present study, which was approved by the Institutional An-
imal Care and Ethics Committee. The sheep received humane care in com-
pliance with the ‘‘Guide for the Care and Use of Laboratory Animals’’
prepared by the Institute of Laboratory Animals Resources, National
Research Council, 1996. Anesthesia was induced by alfaxalone
(5–10 mg/kg) and maintained with 50% oxygen, 45%/50% nitrous oxide,
and 2% isoflurane. Regular blood gas measurements confirmed physio-
logic ventilation and oxygenation.
Study Design
The sheep were acclimatized for more than 2 weeks before randomiza-
tion into 2 groups. Selective percutaneous over-the-wire catheterization of
the main septal perforating artery (MSPA) was followed by either sham or
active percutaneous transluminal septal myocardial ablation of the artery
(PTSMA).17 After 4 weeks of recovery, the RV hemodynamic and dimen-
sional changes were measured in response to custom-designed HeartPatch
DCC placement and its actuation in 5 modes: no device use, passive place-
ment of the DCC device, and LV, RV, or biventricular actuation.15,18
Interventricular Septal Ablation
For interventricular (IV) septal ablation, a 53-cm, transvenous, active
fixation, bipolar pacemaker lead (Capsure SP-4524; Medtronic Corpora-
tion, Minneapolis Minn) was secured to the RV apex and connected to
the Medtronic pacemaker (Sigma Series SR 300; Medtronic Corporation)210 The Journal of Thoracic and Cardiovascular Surgset to activate at a hysteresis of 50 bpm and pace at 80 ppm as a rescue de-
vice for high-grade heart block. A 2.03 9-mm over-the-wire balloon cath-
eter (Maverick SoftLEAP; Boston Scientific, Boston, Mass) mounted on
a 0.014-in. hydrocoat guidewire (Hi Torque Balance Middleweight; Gui-
dant, St Paul, Minn) was angiographically guided from the carotid artery
into the MSPA with proximal clearance of the left anterior descending
artery. Confirmed correct positioning of the balloon markers within the
MSPAwith angiographically verified arterial patency was considered com-
pletion of sham ablation. For septal ablation, a bolus volume of 0.6 mL
99.6% ethanol was delivered immediately after balloon inflation to 8
atm. At 10 minutes after balloon inflation, the catheter was removed, and
MSPA closure was angiographically verified. The history of the pacemaker
performance was checked 4 weeks later, followed by a terminal hemody-
namic study, and the heart was harvested for histologic analysis. Confirma-
tion of the ablation/infarction pathologic features followed selectiveMSPA
perfusion using 1% triphenyltetrazolium solution and simultaneous differ-
ential staining through the left main and right coronary arteries.17
Hemodynamic Instrumentation
After cannulation of the left jugular vein and carotid artery, a transve-
nous 6F Swan-Ganz catheter was advanced to the pulmonary artery and
a 5F Millar micromanometer-tipped catheter was placed in the RV. A
36F Fogarty catheter placed in the inferior vena cava enabled transient oc-
clusion. The heart and great vessels were accessed through a left thoracot-
omywith removal of the fifth rib. After incision of the pericardium from the
apex to its reflection, Transonic flow probes (MA-16 and MA-20PAX;
Transonic Systems, Natick, NY) were placed around the ascending aorta
and pulmonary trunk. Ten digital, omnidirectional, transceiver sonomi-
crometer crystals (2-mm Silastic; Sonometrics, London, Ontario, Canada)
were attached in the epicardial and endocardial positions.17 Other crystals
were positioned in an equatorial plane across the cardiac short axis to mea-
sure the RVand LV internal dimension and the thickness of the LV, RV free
wall, and septum. Their position was confirmed at autopsy.
HeartPatch DCC Placement
Drivelines for the HeartPatch DCC were passed through incisions in the
pericardial apex and exited the subcostal space, inferior to the xiphisternumery c July 2011
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The Journal of Thoracic and Cathrough two 8-mm midline incisions, and were connected to a custom-
designed drive unit. The HeartPatch DCC epicardial surfaces were
apposed to the respective ventricles, and their edges were secured to the
posterior and anterior pericardium using 3-0 Proline sutures. The
pericardium was loosely closed around the patches with a series of four
5-0 Proline interrupted sutures.
Hemodynamic Measurements
The hemodynamic measurements at end expiration after more than 30
minutes of stable anesthesia were as follows: (1) central venous pressure,
pulmonary artery pressure, and pulmonary capillary wedge pressure
(Swan-Ganz catheter); (2) RV systolic pressure (Millar pressure tip cathe-
ter); and (3) RV volume using sonomicrometers and an ellipsoid subtrac-
tion model,19 with the stroke volume calibrated against the pulmonary
flow probe, (4) indexes of ejection fraction, RV stroke work,20 RVend sys-
tolic elastance (Ees), RV preload recruitable stroke work (PRSW),21 and
RV diastolic relaxation constant (Tau)22 from integrated pressure and vol-
ume loop data using Conduct-PC software, version 2.3.1 (Cardiodynamics,
Rijinsberg, The Netherlands),23 and (5) geometric measurements from raw
sonomicrometric data.
Data Analysis
The RV internal septal-lateral end-diastolic (ED) and end-systolic (ES)
short-axis dimensionswere analyzed as previously described.17 EDwas de-
fined as the interval of the peak electrocardiographic R wave and LV ES
and RV ES as the point of zero aortic or pulmonary flow, respectively.
Steady state hemodynamic parameters represented the average of 8 to 10
beats. An operator unaware of the treatment groups analyzed coded,
randomized, digital, histologic photos by planimetry (Sigma Scan Image,
version 2.03; SPSS, Chicago, Ill).
Statistical Analysis
The results are reported as the mean or percentage SD, as appropriate.
For all parameters, the comparisons over time and between groups were
calculated using repeated measures analysis of variance (SigmaStat Statis-
tical Software, version 2.03; SPSS).RESULTS
Of the 15 sheep studied, 12 were used for the analysis; 6 in
the septal ablation group and 6 in the control group. Of the
remaining 3 sheep, 2 had died acutely of heart failure and/
or irrecoverable arrhythmias after PTSMA and 1 was killed
after embolization of a fractured angiowire fragment.E
T
/B
SLoad-Independent Systolic and Diastolic Function
The RV PRSW, RV Ees, and RV Tau patterns (Table 1
and Figure 2) were affected by the mode of DCC assist
used (P< 0.001) and the presence of IV septal infarction
(PTSMA, P<.001). The RV PRSW and Ees pattern across
various implementations of DCC showed that all forms
of active DCC improved the RV functional indexes.
A proportionally greater increase occurred in the RV
PRSW index during LVDCC in the control sheep compared
with the study sheep (190.6  23.5 vs 135.0  40.8
erg*10^3). In contrast, a proportionally greater increase oc-
curred in the RV Ees in the PTSMA sheep during RV DCC
than in the control sheep (17.29  3.40 vs 9.88  2.01 mm
Hg/mL, respectively). Before device placement, the RV Taurdiovascular Surgery c Volume 142, Number 1 211
FIGURE 2. Load-independent hemodynamic effects of direct cardiac
compression (DCC) in control and percutaneous transluminal septal myo-
cardial ablation of the artery (PTSMA) sheep. RV PRSW, right ventricular
preload recruitable stroke work; RV Ees, right ventricular end-systolic ela-
stance; RV Tau, right ventricular diastolic relaxation constant; BiV, biven-
tricular. (yP  .01 compared with no-device value; *P  .01, PTSMA vs
control). Note: active modes of DCC increased right ventricular systolic
pressure, right ventricular strokework, and RVEes. Compared with control
group, PTSMA group had increased Ees during RV DCC and decreased
PRSW during LV DCC. No significant differences seen between control
and PTSMA sheep in any of remaining indexes or DCC modes.
FIGURE 3. In-series hemodynamic effects of direct cardiac compression
(DCC) in control and percutaneous transluminal septal myocardial ablation
of the artery (PTSMA) sheep. Control group demonstrated greater right
ventricular systolic pressure (RVP) during biventricular (BiV) DCC and
left ventricular (LV) DCC compared with PTSMA sheep. CVP, central ve-
nous pressure; PCWP, pulmonary capillary wedge pressure; RVEF, right
ventricular ejection fraction; RVCO, right ventricular cardiac output.
*P  .01, PTSMA vs control group.
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Swas lower in the PTSMA sheep than in the control group
(20.0  2.1 vs 23.5  2.3 ms), a difference no longer
observed in any of the compression modes.
Load-Dependent RV Function
The load-dependent hemodynamic data are listed in
Table 1 and shown in Figures 3 and 4. The RV systolic
pressure, PCWP, and RV stroke work (SW) patterns were
affected by DCC assist (P<.001) and the presence of IV
septal infarction (PTSMA). The biventricular DCC and
RV DCC increased the RV systolic pressure to a greater
extent in the PTSMA group than in the control group
(47.7  4.6 vs 37.9  6.3 mm Hg and 40.3%  8.3% vs
29.7%  4.8%, respectively). Furthermore, the generated
RV SW was greater during LV DCC in the control sheep
and during RV DCC in the PTSMA sheep (6626  1107212 The Journal of Thoracic and Cardiovascular Surgvs 5104  1411 mm Hg*mL and 12,438  4006 vs 8712
 3416 mm Hg*mL, respectively; Figure 4).Dimensional Changes
The RV internal septal-lateral short-axis dimension
response to DCC is summarized in Table 2.
The fractional change of the RV ED to RV ES dimension
was reduced during LVDCC actuation to a greater degree in
the control sheep (ED 98.2%  5.0% to ES 70.1% 
15.9% ¼ 28.6% change; ED 98.9%  5.6% to ES
90.5%  5.0% ¼ 9.0% change, *, P<.001). In contrast,
it was reduced to a greater degree during RV DCC in the
PTSMA sheep (ED 125.7%  25.0% to ES 50.1% 
12.6% ¼ 60.1% change; ED 122.1%  12.4% to ESery c July 2011
FIGURE 4. Effect of variable modes of HeartPatch direct cardiac com-
pression (DCC) on right ventricular (RV) stroke work (SW). RV SW during
left ventricular (LV) DCC was greater in control group but was greater in
PTSMA group during RV DCC. *P  .01, PTSMA vs control.
Mau et al Evolving Technology/Basic Science63.4%  14.2% ¼ 48.1% change, *, P<.001). No other
difference was found between the 2 groups.DISCUSSION
The major findings of the present study were first that the
presence of IV septal infarction altered the effect of various
DCC modes. Second, HeartPatch DCC device placement
within the pericardial cavity did not affect systolic or dia-
stolic function. Third, bi- and univentricular assist both
led to a substantial increase in cardiac output and a lowering
of the central venous pressure, irrespective of IV septal
damage. Fourth, bi- and univentricular DCC actuation
both augmented the native Frank-Starling response, as dem-
onstrated by a marked increase in the PRSW. This brings
into question current opinion. Fifth, RV DCC actuation
increased load-independent RV function in excess of LVac-
tuation. Finally, the effect of LV DCC actuation using
compressive energy delivery was curtailed in the presenceTABLE 2. Right ventricular septal to lateral wall distances at end-diastol
DCC
RV septal-lateral
short axis
dimension (%)
HeartPatch
No device Passive placement BiV
ED ES ED ES ED
Control 100  0 100  0 98.4  3.3 98.4  6.1 120.6  9.7
PTSMA 100  0 100  0 99.5  2.4 100.6  4.8 113.6  10
RV, right ventricular; DCC, direct cardiac compression; BiV, biventricular; LV, left ventric
myocardial ablation of artery. *P  .001  SD, PTSMA vs control.
The Journal of Thoracic and Caof IV septal infarction but enhanced when the right patch
was also actuated.
Load-Independent Response of RV to DCC
The load-independent results of the present study have
added significant credibility to its findings with the use of
DCC, with markedly increased PRSW and Ees from both
bi- and univentricular RV compression compared with
isolated LV actuation (Table 1 and Figure 2). This RV
response has demonstrated that the HeartPatch DCC en-
gages a Frank-Starling relationship in response to altering
preload, as evidenced by an increase in the slope of the
ES pressure/volume relationship (ESPVR), a phenomenon
not previously described.
A parallel shift in the ESPVR with an unaltered slope
(elastance-Ees) has been the previously predicted response
to DCC,24,25 where on external compression of the heart,
the dynamic ventricular volume window shifts to the left,
creating a new equilibrium of smaller ED and ES
volumes. The slope of the ESPVR (Ees) will remain
constant, and the predicted volume at 0 mm Hg (‘‘V0’’)
will be reduced. The physiologic F-S response within the
native myocardium entails a minimally altered ES
volume, an increased ED volume (with an increase in
stroke volume), and an increase in cardiac output. The
slope of the ESPVR (Ees) increases proportionally,
indicative of enhanced contractility.
For this response to manifest during dynamic DCC, the
mechanical compression must be capable of responding to
increased venous return. This translates to enhanced epicar-
dial compressive pressure delivery as the volume increases.
Such external compressive engagement of the Frank-
Starling mechanism has only been previously observed
with dynamic cardiomyoplasty.26-28
Our results have demonstrated that this dynamic enhance-
ment capability also extends to the HeartPatch DCC device,
with Ees increasing from 0.8 to 11 mm Hg/mL with biven-
tricular DCC. We propose that this relates to the device’s
‘‘nonsurround’’ design, aimed at removing the constrictive
effects of its ‘‘heart-surround’’ counterparts.
Load-Dependent and RV Diastolic Response to DCC
Although the RV systolic pressure increased in both
experimental groups, the biventricular and single-RVe and end-systole in both groups during various modes of HeartPatch
DCC compression mode
DCC LV DCC RV DCC
ES ED ES ED ES
55.9  11.5 98.2  5.0 70.1  15.9* 122.1  12.4 63.4  14.2
.0 47.4  10.1 98.9  5.6 90.5  5.0 125.7  21.0 50.1  12.6*
ular; ED, end-diastolic; ES, end-systolic; PTSMA, percutaneous transluminal septal
rdiovascular Surgery c Volume 142, Number 1 213
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SDCC actuation caused a greater increase in the heart with
septal ablation (Table 1 and Figure 2). No other differ-
ences in the load-dependent indexes were observed
between the control sheep or those with an infarcted IV
septum. Given the greater RV systolic pressure in the IV
septum-ablated sheep after RV patch actuation, septal fi-
brosis appeared to lessen the translational loss of pressure
to the LV owing to a ‘‘buttressing’’ effect, which confined
the bulk of DCC energy delivery to the RV. Additional
support for this premise was reflected in the greater RV
SW values seen in the IV septal-ablated sheep during
RV patch actuation, which also explains, by way of recip-
rocation, the lower RV SW values observed in the PTSMA
sheep during univentricular LV DCC (Figure 4). Our pre-
vious studies have shown that cardiomyoplasty can also
enhance external SW.28
We have previously shown, under closed chest condi-
tions, that PTSMA alone leads to prolonged Tau.17 How-
ever, we did not observe this in the present study, in
which Tau was paradoxically reduced by IV septal ablation.
The difference most likely reflects the effect of pericardiot-
omy in an open chested animal.
Despite the likelihood of diastolic interference from
DCC surround devices, this issue has not received signifi-
cant attention.12 The initial concerns about the potential
tamponade using the HeartPatch device were overcome
by placement of a series of longitudinal pericardial
incisions.
Geometric Response to DCC
The aim of DCC is to provide hemodynamic stabilization
by enhancing the approximation of heart contractile ele-
ments in all 3 geometric axes. Our previous work showed
that the HeartPatch DCC device increased the lateral
short-axis fractional change during systole. However, dur-
ing normal systolic contraction, in which reduction in the
anterior-posterior axis would be expected, paradoxic
lengthening was found with DCC.18 Cavity volume reduc-
tion was achieved because the septal-lateral short-axis
change exceeded the anterior-posterior lengthening.
The only significant differences between the IV septal-
ablated and control sheep were in the relative reductions
of the RV ES dimension in the former during RV DCC
and the latter during LV DCC. The enhanced systolic ben-
efit during RV DCC and the reduced benefit during LV
DCC in the PTSMA sheep were most likely a result of
chamber containment of energy delivery during RV DCC
and decreased transmission of LV free wall compression
brought about by a stiffened, fibrosed septum. It is clear
from our results that even though the IV septal diastolic po-
sition remains unaffected, the ES septal-lateral dimension
will be decreased with all modes of DCC actuation. This
was shown by an increase in the fractional change of the
endocardial septal-lateral RV dimension.214 The Journal of Thoracic and Cardiovascular SurgStudy Limitations
The effects of DCC were assessed using an open chest
model. It is possible that the hemodynamic effects of intra-
pericardially placed devices in a closed chest model would
be different. Furthermore, the hemodynamic effects of DCC
were only measured from minutes to hours.
Heart functionwas assessed in an experimental model de-
signed to address specific physiologic questions, rather than
a heart failuremodel, to reduce potential confounders. Thus,
we have not applied the septal injurymodel to a failing heart.
Thepresent studywasdesigned to assess theRV functional
response to DCC to compare it with previous investigations
of LV unloading devices.35 The LV response to DCC was
not addressed.We have indirectly suggested that PTSMA re-
duces translational energy delivery through IV septal tissue
during univentricular DCC by observation of the relative dif-
ferences in RV SW, systolic pressure, and dimensional
changes during LV/RVDCC. To confirm this premise, inves-
tigations of comparative LV indexes are needed.CONCLUSIONS
The HeartPatch DCC device conferred effective RV sup-
port and maintained RV function, irrespective of chronic
septal damage, with evidence of recruitment of a Frank-
Starling relationship. This contrasts with the traditional
flow-through LV unloading devices. Furthermore, diastolic
impairment was not evident under open chest conditions.
Device-based advances in the treatment of heart failure
have recently included minimally invasive LVAD axial
flow devices,5,29 LVAD endovascular coatings,30 improve-
ments in total artificial heart design,31,32 and cardiac
resynchronization therapy.33,34 DCC forms of cardiac
assist have the potential to provide effective LV and RV
support, particularly in cases in which RV dysfunction is
commonly induced after placement of an LV unloading
device for severe heart failure.
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